These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21883692)

  • 21. Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy.
    Lee JY; Lee YM; Chang GC; Yu SL; Hsieh WY; Chen JJ; Chen HW; Yang PC
    PLoS One; 2011; 6(8):e23756. PubMed ID: 21858220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P21 (waf1/cip1) is required for non-small cell lung cancer sensitive to Gefitinib treatment.
    Zhao YF; Wang CR; Wu YM; Ma SL; Ji Y; Lu YJ
    Biomed Pharmacother; 2011 Jun; 65(3):151-6. PubMed ID: 21616632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Palbociclib, a selective CDK4/6 inhibitor, enhances the effect of selumetinib in RAS-driven non-small cell lung cancer.
    Zhou J; Zhang S; Chen X; Zheng X; Yao Y; Lu G; Zhou J
    Cancer Lett; 2017 Nov; 408():130-137. PubMed ID: 28866094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo.
    Meng J; Dai B; Fang B; Bekele BN; Bornmann WG; Sun D; Peng Z; Herbst RS; Papadimitrakopoulou V; Minna JD; Peyton M; Roth JA
    PLoS One; 2010 Nov; 5(11):e14124. PubMed ID: 21124782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo inhibitory effect of the combination of Wenxia Changfu formula [see text] with cisplatin in non-small cell lung cancer.
    Ji XM; Ouyang B; Liu H; Liu GW; Wu ZC; Yu HY; Wang CY; Wang ZX; Wang WP
    Chin J Integr Med; 2011 Dec; 17(12):908-16. PubMed ID: 22139542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells.
    Tsai AC; Pai HC; Wang CY; Liou JP; Teng CM; Wang JC; Pan SL
    Br J Pharmacol; 2014 Jan; 171(1):122-33. PubMed ID: 24116948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of hepatocellular carcinoma proliferation and hepatitis B surface antigen secretion with interferon-λ1 or PEG-interferon-λ1.
    Tian S; Hui X; Fan Z; Li Q; Zhang J; Yang X; Ma X; Huang B; Chen D; Chen H
    FASEB J; 2014 Aug; 28(8):3528-39. PubMed ID: 24769671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
    Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
    Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.
    Lee TH; Chuang LY; Hung WC
    Oncogene; 1999 Jul; 18(29):4269-74. PubMed ID: 10435640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models.
    Kang HN; Kim SH; Yun MR; Kim HR; Lim SM; Kim MS; Hong KW; Kim SM; Kim H; Pyo KH; Park HJ; Han JY; Youn HA; Chang KH; Cho BC
    Lung Cancer; 2016 May; 95():57-64. PubMed ID: 27040853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Grape proanthocyanidins induce apoptosis by loss of mitochondrial membrane potential of human non-small cell lung cancer cells in vitro and in vivo.
    Singh T; Sharma SD; Katiyar SK
    PLoS One; 2011; 6(11):e27444. PubMed ID: 22087318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly Expressed FOXF1 Inhibit Non-Small-Cell Lung Cancer Growth via Inducing Tumor Suppressor and G1-Phase Cell-Cycle Arrest.
    Wu CY; Chan CH; Dubey NK; Wei HJ; Lu JH; Chang CC; Cheng HC; Ou KL; Deng WP
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis and growth inhibition of squamous carcinoma cells treated with interferon-alpha, IFN-beta and retinoic acid are associated with induction of the cyclin-dependent kinase inhibitor p21.
    Giandomenico V; Vaccari G; Fiorucci G; Percario Z; Vannuchi S; Matarrese P; Malorni W; Romeo G; Affabris GR
    Eur Cytokine Netw; 1998 Dec; 9(4):619-31. PubMed ID: 9889406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer.
    Smith DL; Acquaviva J; Sequeira M; Jimenez JP; Zhang C; Sang J; Bates RC; Proia DA
    Target Oncol; 2015 Jun; 10(2):235-45. PubMed ID: 25077897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-31/QKI-5 axis facilitates cell cycle progression of non-small-cell lung cancer cells by interacting and regulating p21 and CDK4/6 expressions.
    Zhu W; Yu Y; Fang K; Xiao S; Ni L; Yin C; Huang X; Wang X; Zhang Y; Le HB; Cui R
    Cancer Med; 2023 Feb; 12(4):4590-4604. PubMed ID: 36172919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma.
    Wang CJ; Xiao CW; You TG; Zheng YX; Gao W; Zhou ZQ; Chen J; Xue XB; Fan J; Zhang H
    Mol Cancer; 2012 May; 11():31. PubMed ID: 22569271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-lambda induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents.
    Li Q; Kawamura K; Ma G; Iwata F; Numasaki M; Suzuki N; Shimada H; Tagawa M
    Eur J Cancer; 2010 Jan; 46(1):180-90. PubMed ID: 19879751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-6 overcomes p21WAF1 upregulation and G1 growth arrest induced by dexamethasone and interferon-gamma in multiple myeloma cells.
    Urashima M; Teoh G; Chauhan D; Hoshi Y; Ogata A; Treon SP; Schlossman RL; Anderson KC
    Blood; 1997 Jul; 90(1):279-89. PubMed ID: 9207463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines.
    Baharuddin P; Satar N; Fakiruddin KS; Zakaria N; Lim MN; Yusoff NM; Zakaria Z; Yahaya BH
    Oncol Rep; 2016 Jan; 35(1):13-25. PubMed ID: 26531053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.